Long Term Debt - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Long-Term Debt Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Long-Term Debt
$41.4m
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
13%
Repare Therapeutics Inc
NASDAQ:RPTX
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Long-Term Debt
$64.9m
CAGR 3-Years
N/A
CAGR 5-Years
193%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Long-Term Debt
CA$412.7k
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
-4%
Spectral Medical Inc
TSX:EDT
Long-Term Debt
CA$12.6m
CAGR 3-Years
186%
CAGR 5-Years
78%
CAGR 10-Years
N/A

See Also

What is Portage Biotech Inc's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Long-Term Debt amounts to 0 USD.

Back to Top